SEARCH RESULTS FOR: "Tag: TEVA"
REFINE YOUR SEARCH:
RECENT
Last Month(2)
ARTICLES/BLOGS
2019(7)
2018(16)
2017(41)
2016(13)
2015(15)
CATEGORIES
5-Minute Market Rundown(4)
Analyst Downgrades(7)
Analyst Update(16)
Analyst Upgrades(3)
Buzz Stocks(23)
By the Numbers(1)
Earnings Preview(1)
Expectational Analysis(2)
Ezines(1)
General(7)
Intraday Option Activity(5)
Market Recap(2)
Midday Market Check(6)
Opening View(15)
Quantitative Analysis(2)
Stock Market News(6)
Stocks On the Move(5)
Technical Analysis(1)

5/13/2019 2:10 PM
It's been a rough stretch for Mylan NV (NASDAQ:MYL) stock, which is down more than 30% since its May 6 intraday peak at $28.46, due in part to last week's post-earnings bear gap. Options traders hav...
5/13/2019 10:43 AM
Drugmaker Teva Pharmaceutical Industries Ltd (NYSE:TEVA) is tanking this morning, last seen down 12.7% at $12.53, after several U.S. states filed a price-fixing lawsuit against the company, accusing i...
3/26/2019 2:21 PM
Teva Pharmaceutical Industries Ltd (NYSE:TEVA) is in the news today, after OxyContin maker Purdue Pharma and several members of the Sackler family, which own the company, reached a $270 million settle...
2/20/2019 11:48 AM
The Dow Jones Industrial Average (DJI) is clinging to marginal gains at midday, as investors await the release of the latest Fed meeting minutes. There are no new trade developments between the U.S...
2/13/2019 10:00 AM
The shares of Teva Pharmaceutical Industries Ltd (NYSE:TEVA) have plunged 10% out of the gate to trade at $17.17, after the generic drugmaker reported a fourth-quarter adjusted profit miss of 53 cent...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center